The ReTain study at the Oxford Health Clinical Research Facility (OH CRF) is looking for volunteers aged 55-75 without a memory condition to evaluate the safety and effectiveness of an immunotherapy treatment in slowing the progression of Alzheimer’s Disease.
Participation involves:
- 22 clinic visits and 4 phone calls over 4 years
- Completion of a participant diary
- Scans
- Cognitive tests
Recruitment to the study is open until December 2026.
Those with a diagnosis of Alzheimer’s Dementia or non-Alzheimer’s Dementia would not be eligible to participate.
Those with history or current neurological disease would not be eligible to participate.
To learn more, contact [email protected] today
